Stockscreener 앱 받기
4.70
3.39%
-0.165
전일 마감가:
$4.865
열려 있는:
$4.835
하루 거래량:
15.02M
Relative Volume:
0.57
시가총액:
$2.01B
수익:
$64.60M
순이익/손실:
$-377.75M
주가수익비율:
-3.0323
EPS:
-1.55
순현금흐름:
$-335.64M
1주 성능:
-4.86%
1개월 성능:
-21.01%
6개월 성능:
-38.72%
1년 성능:
-36.57%
1일 변동 폭
$4.63
$4.895
1주일 범위
$4.63
$5.03
52주 변동 폭
$3.79
$12.36
리커젼 파마 Stock (RXRX) Company Profile
명칭
Recursion Pharmaceuticals Inc
전화
(385) 269-0203
주소
41S RIO GRANDE STREET, SALT LAKE CITY
RXRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
4.70 | 2.11B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
리커젼 파마 Stock (RXRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-05-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-03-16 | 개시 | Needham | Buy |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-03-04 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | 개시 | Berenberg | Buy |
| 2021-05-11 | 개시 | BofA Securities | Buy |
| 2021-05-11 | 개시 | Goldman | Neutral |
| 2021-05-11 | 개시 | JP Morgan | Neutral |
| 2021-05-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | 개시 | SVB Leerink | Outperform |
모두보기
리커젼 파마 주식(RXRX)의 최신 뉴스
Quantitative breakdown of Recursion Pharmaceuticals Inc. recent moveWeekly Investment Summary & Free High Return Stock Watch Alerts - Newser
Needham Maintains Buy Rating on Recursion (RXRX) - MSN
Performance Recap: Is Recursion Pharmaceuticals Inc. a strong growth stockQuarterly Risk Review & Short-Term Swing Trade Alerts - خودرو بانک
Market reaction to Recursion Pharmaceuticals Inc.’s recent newsOil Prices & Long-Term Growth Stock Strategies - Newser
Momentum Screeners Rank Recursion Pharmaceuticals Inc. in Top 5 TodayPortfolio Gains Summary & Daily Technical Stock Forecast Reports - beatles.ru
Earnings visualization tools for Recursion Pharmaceuticals Inc.2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Is now a turning point for Recursion Pharmaceuticals Inc.Earnings Risk Summary & Precise Entry and Exit Recommendations - Newser
Historical volatility pattern of Recursion Pharmaceuticals Inc. visualizedTrade Risk Summary & High Accuracy Trade Alerts - Newser
Visualizing Recursion Pharmaceuticals Inc. stock with heatmapsWeekly Trade Recap & Verified Technical Trade Signals - Newser
Ranking Recursion Pharmaceuticals Inc. among high performing stocks via tools2025 Fundamental Recap & Consistent Profit Alerts - Newser
Measuring Recursion Pharmaceuticals Inc.’s beta against major indicesQuarterly Profit Review & Technical Pattern Based Signals - Newser
Multi asset correlation models including Recursion Pharmaceuticals Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser
What’s next for Recursion Pharmaceuticals Inc. stock priceWeekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Recursion Pharmaceuticals Inc. stock trend outlook and recovery pathWeekly Profit Analysis & High Conviction Buy Zone Alerts - Newser
Momentum divergence signals in Recursion Pharmaceuticals Inc. chartDividend Hike & Free Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Recursion Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry and Exit Trade Signals - Newser
Can Recursion Pharmaceuticals Inc. hit a new high this monthQuarterly Market Review & Step-by-Step Trade Execution Guides - Newser
Combining price and volume data for Recursion Pharmaceuticals Inc.2025 Technical Overview & Smart Investment Allocation Tips - Newser
Can technical indicators confirm Recursion Pharmaceuticals Inc.’s reversal - Newser
Recursion Pharmaceuticals Inc. stock prediction for this weekWeekly Gains Summary & Risk Adjusted Swing Trade Ideas - Newser
Real time breakdown of Recursion Pharmaceuticals Inc. stock performanceWeekly Investment Report & Community Trade Idea Sharing - Newser
Pattern recognition hints at Recursion Pharmaceuticals Inc. upsideWeekly Stock Recap & Consistent Growth Stock Picks - Newser
Applying chart zones and confluence areas to Recursion Pharmaceuticals Inc.July 2025 Chart Watch & Risk Adjusted Buy and Sell Alerts - Newser
Will Recursion Pharmaceuticals Inc. stock recover after recent drop2025 Investor Takeaways & Risk Managed Trade Strategies - Newser
Tools to monitor Recursion Pharmaceuticals Inc. recovery probabilityQuarterly Portfolio Report & Smart Money Movement Alerts - Newser
How to manage a losing position in Recursion Pharmaceuticals Inc.July 2025 Snapshot & Risk Controlled Daily Trade Plans - Newser
Can machine learning forecast Recursion Pharmaceuticals Inc. recovery2025 Momentum Check & Weekly Sector Rotation Insights - Newser
Will Recursion Pharmaceuticals Inc. benefit from macro trendsGlobal Markets & Expert Approved Trade Ideas - Newser
Real time pattern detection on Recursion Pharmaceuticals Inc. stockWeekly Trade Analysis & Accurate Technical Buy Alerts - Newser
Using AI based signals to follow Recursion Pharmaceuticals Inc.Earnings Growth Report & Expert Verified Movement Alerts - Newser
Multi factor analysis applied to Recursion Pharmaceuticals Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - Newser
Is it too late to sell Recursion Pharmaceuticals Inc.2025 Key Lessons & Weekly Watchlist for Hot Stocks - Newser
리커젼 파마 (RXRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):